Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petr Chytil

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Pharmaceutics|September 25, 2019
Fluorescence Imaging as a Tool in Preclinical Evaluation of Polymer-Based Nano-DDS Systems Intended for Cancer TreatmentTomáš Etrych, Olga Janoušková, Petr Chytil
Journal of Personalized Medicine|February 13, 2021
HPMA Copolymer-Based Nanomedicines in Controlled Drug DeliveryPetr Chytil, Libor Kostka, Tomáš Etrych
Anti-Cancer Drugs|September 14, 2017
Ability of polymer-bound P-glycoprotein inhibitor ritonavir to overcome multidrug resistance in various resistant neuroblastoma cell linesEva Koziolová, Petr Chytil, Tomáš Etrych, et al.
Macromolecular Bioscience|August 15, 2017
HPMA Copolymer-Drug Conjugates with Controlled Tumor-Specific Drug ReleasePetr Chytil, Eva Koziolová, Tomáš Etrych, et al.
Macromolecular Bioscience|May 19, 2021
Polymer-Based Drug-Free Therapeutics for Anticancer, Anti-Inflammatory, and Antibacterial TreatmentMarina Rodrigues Tavares, Michal Pechar, Petr Chytil, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 11, 2010
N-(2-Hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin for cell-specific or passive tumour targeting. Synthesis by RAFT polymerisation and physicochemical characterisationPetr Chytil, Tomáš Etrych, Jaroslav Kříž, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 20, 2016
Fluorescence optical imaging in anticancer drug deliveryTomáš Etrych, Henrike Lucas, Olga Janoušková, et al.
Molecular Pharmaceutics|July 12, 2019
Superior Penetration and Cytotoxicity of HPMA Copolymer Conjugates of Pirarubicin in Tumor Cell SpheroidHideaki Nakamura, Eva Koziolová, Petr Chytil, et al.
Macromolecular Bioscience|March 4, 2015
Synthesis and Properties of Star HPMA Copolymer Nanocarriers Synthesised by RAFT Polymerisation Designed for Selective Anticancer Drug Delivery and ImagingPetr Chytil, Eva Koziolová, Olga Janoušková, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 4, 2018
Nanotherapeutics with suitable properties for advanced anticancer therapy based on HPMA copolymer-bound ritonavir via pH-sensitive spacersDaniela Machová, Eva Koziolová, Petr Chytil, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Pharmaceutics|September 25, 2019
Fluorescence Imaging as a Tool in Preclinical Evaluation of Polymer-Based Nano-DDS Systems Intended for Cancer TreatmentTomáš Etrych, Olga Janoušková, Petr Chytil
Journal of Personalized Medicine|February 13, 2021
HPMA Copolymer-Based Nanomedicines in Controlled Drug DeliveryPetr Chytil, Libor Kostka, Tomáš Etrych
Anti-Cancer Drugs|September 14, 2017
Ability of polymer-bound P-glycoprotein inhibitor ritonavir to overcome multidrug resistance in various resistant neuroblastoma cell linesEva Koziolová, Petr Chytil, Tomáš Etrych, et al.
Macromolecular Bioscience|August 15, 2017
HPMA Copolymer-Drug Conjugates with Controlled Tumor-Specific Drug ReleasePetr Chytil, Eva Koziolová, Tomáš Etrych, et al.
Macromolecular Bioscience|May 19, 2021
Polymer-Based Drug-Free Therapeutics for Anticancer, Anti-Inflammatory, and Antibacterial TreatmentMarina Rodrigues Tavares, Michal Pechar, Petr Chytil, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 11, 2010
N-(2-Hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin for cell-specific or passive tumour targeting. Synthesis by RAFT polymerisation and physicochemical characterisationPetr Chytil, Tomáš Etrych, Jaroslav Kříž, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 20, 2016
Fluorescence optical imaging in anticancer drug deliveryTomáš Etrych, Henrike Lucas, Olga Janoušková, et al.
Molecular Pharmaceutics|July 12, 2019
Superior Penetration and Cytotoxicity of HPMA Copolymer Conjugates of Pirarubicin in Tumor Cell SpheroidHideaki Nakamura, Eva Koziolová, Petr Chytil, et al.
Macromolecular Bioscience|March 4, 2015
Synthesis and Properties of Star HPMA Copolymer Nanocarriers Synthesised by RAFT Polymerisation Designed for Selective Anticancer Drug Delivery and ImagingPetr Chytil, Eva Koziolová, Olga Janoušková, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 4, 2018
Nanotherapeutics with suitable properties for advanced anticancer therapy based on HPMA copolymer-bound ritonavir via pH-sensitive spacersDaniela Machová, Eva Koziolová, Petr Chytil, et al.
Pageof 6